Detection of Chlamydia pneumoniae (Chlamydophila pneumoniae) DNA in atherosclerotic plaques and its molecular analysis in northern Greece

Objectives : C. pneumoniae responsible for respiratory tract infections has also been assocciated with chronic diseases such as atherosclerosis.The aim of the present study is the detection of C. pneumoniae DNA in various atherosclerotic arteries by a sensitive and specific PCR. In order to investigate whether there is a relation between a specific type and atherosclerosis, genotyping was performed. Methods: The study group consisted of 122 atherosclerotic plaques from patients (mean age 68.4, range 50-89 years old, 95 males and 25 females) with severe atherosclerosis. C. pneumoniae DNA was detected in atherosclerotic plaques by nested «Touchdown» PCR. A second PCR targeting the ygeD-urk intergenic region was performed and PCR products were sequenced.Results: 12.3% of the specimens were positive for C. pneumoniae. Detection rates in specimens of carotid, abdominal, and femoral arteries were 12%, 15.6%, and 10%, respectively. (p = NS). 14 strains were found to have 100% homology with J138, AR39 and TW-183, while one strain had a 23 bp invertible region and revealed 100% homology with the CWL029. Conclusion : Overall, 15/122 (12.3%) atherosclerotic specimens from patients were positive for C. pneumoniae. The strains detected belong to two different types designated as genotype I and II. Genotype I was the prevalent and only one strain had the reverse orientation of the 23bp region in northern Greece.

[1]  P. Timms,et al.  Molecular characterization of Chlamydophila pneumoniae isolates from Western barred bandicoots. , 2007, Journal of medical microbiology.

[2]  P. Timms,et al.  Multiple genotypes of Chlamydia pneumoniae identified in human carotid plaque. , 2005, Microbiology.

[3]  D. Waters,et al.  Chlamydia Pneumoniae and Atherosclerosis: From Koch Postulates to Clinical Trials , 2005, Progress in Cardiovascular Diseases.

[4]  M. Ieven,et al.  Involvement of Chlamydia pneumoniae in Atherosclerosis: More Evidence for Lack of Evidence , 2005, Journal of Clinical Microbiology.

[5]  P. Apfalter,et al.  No Evidence of Involvement of Chlamydia pneumoniae in Severe Cerebrovascular Atherosclerosis by Means of Quantitative Real-Time Polymerase Chain Reaction , 2004, Stroke.

[6]  M. Hammerschlag Advances in the management of Chlamydia pneumoniae infections , 2003, Expert review of anti-infective therapy.

[7]  Raúl Moreno,et al.  Chlamydia pneumoniae in the atherosclerotic plaques of patients with unstable angina undergoing coronary artery bypass grafting: does it have prognostic implications? , 2003, International journal of cardiology.

[8]  L. Tokgözoğlu,et al.  Detection of Chlamydia pneumoniae andHelicobacter pylori DNA in Human Atherosclerotic Plaques by PCR , 2000, Journal of Clinical Microbiology.

[9]  S. Salzberg,et al.  Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. , 2000, Nucleic acids research.

[10]  C. Jantos,et al.  Low prevalence of Chlamydia pneumoniae in atherectomy specimens from patients with coronary heart disease. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  P. Apfalter,et al.  Detection of Chlamydia pneumoniae DNA in atheromatous tissues by polymerase chain reaction. , 1999, Wiener klinische Wochenschrift.

[12]  I. Fong,et al.  Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. , 1997, Circulation.

[13]  J. Danesh,et al.  Chronic infections and coronary heart disease: is there a link? , 1997, The Lancet.

[14]  M. Maass,et al.  Endovascular Presence of Chlamydia pneumoniae in Patients with Hemodynamically Effective Carotid Artery Stenosis , 1997, Angiology.

[15]  F. Blasi,et al.  Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms , 1996, Journal of clinical microbiology.

[16]  T. Quinn,et al.  Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. , 1996, The Journal of infectious diseases.

[17]  A. Easton,et al.  Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. , 1993, The Journal of infectious diseases.

[18]  A. Gown,et al.  Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[19]  C. Tong,et al.  Detection of Chlamydia pneumoniae and Chlamydia psittaci in sputum samples by PCR. , 1993, Journal of clinical pathology.

[20]  M. Nieminen,et al.  SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION , 1988, The Lancet.

[21]  C. Minick,et al.  Brief Definitive Report , 2003 .

[22]  C. Frothingham THE RELATION BETWEEN ACUTE INFECTIOUS DISEASES AND ARTERIAL LESIONS , 1911 .

[23]  P. Roffey,et al.  The detection of Chlamydia pneumoniae in atherosclerotic plaques of Australian subjects , 2002, Pathology.

[24]  M. Leinonen,et al.  Evidence for infectious agents in cardiovascular disease and atherosclerosis. , 2002, The Lancet. Infectious diseases.